您当前的位置:首页 >  述职报告 >  述职报告范文 > 内容

化积止痛汤治疗子宫腺肌病痛经的临床观察

材料写作网    时间: 2020-06-17 04:32:20     阅读:


打开文本图片集

摘 要 目的:观察化积止痛汤治疗子宫腺肌病的疗效和安全性。方法:根据纳入标准,随机将符合标准的子宫腺肌病70例平均分为化积止痛汤治疗组和止痛化癥胶囊对照组。观察比较两组患者治疗前及治疗1疗程后痛经积分、月经量评分、子宫体积、CA125水平以及不良反应情况。结果:治疗后3个月,治疗组痛经VAS评分明显低于对照组(P<0.05);治疗组月经量PBAC评分、CA125水平下降显著(P<0.05);两组均未见子宫体积明显缩小。结论:化积止痛汤可以改善子宫腺肌病患者痛经程度、降低月经量及CA125水平,有良好的临床应用价值。

关键词 子宫肌腺病 化积止痛汤 止痛化癥胶囊 临床观察

中图分类号:R289.5; R271.9 文献标志码:B 文章编号:1006-1533(2019)11-0034-03

Clinical observation of Huaji Zhitong decoction in the treatment of adenomyosis

JI Hua1*, CHEN Xiaozhi2, ZHANG Cuiying2**(1. Department of Gynecology and Obstetrics, the Integrated Traditional Chinese and Western Medicine Hospital of Jinshan District, Shanghai 201501, China; 2. Department of Traditional Medicine Gynecology, Guangming Chinese Medicine Hospital of Pudong New Area, Shanghai 201399, China)

ABSTRACT Objective: To observe the efficacy and safety of Huaji Zhitong decoction in the treatment of adenomyosis. Methods: Seventy cases of patients with adenomyosis were randomly divided into a treatment group (oral Huaji Zhitong decoction) and a control group (oral Zhitong Huazheng capsule) based on the inclusion criteria. The dysmenorrhea score, menstrual volume score, uterine volume, CA125 level and adverse reactions were observed before treatment and 1 course after and compared between the two groups. Results: The VAS score of dysmenorrhea in the treatment group was significantly...

== 试读已结束,如需继续阅读敬请充值会员 ==
本站文章均为原创投稿,仅供下载参考,付费用户可查看完整且有格式内容!
(费用标准:38元/2月,98元/2年,微信支付秒开通!)
升级为会员即可查阅全文 。如需要查阅全文,请 免费注册登录会员
《化积止痛汤治疗子宫腺肌病痛经的临床观察.doc》
将本文的Word文档下载到电脑,方便收藏和打印
推荐度:

文档为doc格式

相关热搜

《化积止痛汤治疗子宫腺肌病痛经的临床观察.doc》

VIP请直接点击按钮下载本文的Word文档下载到电脑,请使用最新版的WORD和WPS软件打开,如发现文档不全可以联系客服申请处理。

文档下载
VIP免费下载文档

浏览记录